An Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies : An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies
Medienart: |
Klinische Studie |
---|
Erscheinungsjahr: |
2023 |
---|---|
Erschienen: |
2023 |
Enthalten in: |
WHO International Clinical Trials Registry Platform - (2023) vom: 21. Juni Zur Gesamtaufnahme - year:2023 |
---|
Sprache: |
Englisch |
---|
Links: |
Volltext [kostenfrei] |
---|
Anmerkungen: |
WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 30-04-2019, Last updated: 2023-06-29 |
---|
ICTRP ID: |
EUCTR2018-003459-39-IE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
CTG00427377X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | CTG00427377X | ||
003 | DE-627 | ||
005 | 20230629100623.0 | ||
007 | cr uuu---uuuuu | ||
008 | 210507s2023 xx |||||o 00| ||eng c | ||
035 | |a (DE-627)CTG00427377X | ||
035 | |a (UBBS_Klinische_Studien_WHO)EUCTR2018-003459-39-IE | ||
035 | |a (UBBS_Klinische_Studien_WHO)AG348-C-011 | ||
035 | |a (UBBS_Klinische_Studien_WHO)NCT03853798 | ||
035 | |a (UBBS_Klinische_Studien_WHO)2018-003459-39-DK | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
245 | 1 | 0 | |a An Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies |b An Open-Label, Multicenter, Extension Study of AG-348 in Adult Subjects with Pyruvate Kinase Deficiency Previously Enrolled in AG-348 Studies |
264 | 1 | |c 2023 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a Computermedien |b c |2 rdamedia | ||
338 | |a Online-Ressource |b cr |2 rdacarrier | ||
500 | |a WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 30-04-2019, Last updated: 2023-06-29 | ||
650 | 4 | |a Medical Condition: Pyruvate Kinase DeficiencyHaemolytic anaemia MedDRA version: 21.1Level: PTClassification code 10037682Term: Pyruvate kinase deficiency anaemiaSystem Organ Class: 10010331 - Congenital, familial and genetic disorders;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15] | |
650 | 4 | |a Study Type: Interventional | |
650 | 4 | |a Phase: Phase 3 | |
650 | 4 | |a Recruitment Status: Authorised-recruitment may be ongoing or finished | |
650 | 4 | |a 610 | |
773 | 0 | 8 | |i Enthalten in |t WHO International Clinical Trials Registry Platform |g (2023) vom: 21. Juni |
773 | 1 | 8 | |g year:2023 |g day:21 |g month:06 |
856 | 4 | 0 | |u https://www.clinicaltrialsregister.eu/ctr-search/search?query=eudract_number:2018-003459-39 |z kostenfrei |3 Volltext |
912 | |a GBV_CTG | ||
951 | |a AR | ||
952 | |j 2023 |b 21 |c 06 |